Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guominkang in Diabetic Kidney Disease
NCT07907965Phase 2Active, not recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Oct 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Guominkang in diabetic kidney disease (DKD), sponsored by Beijing University of Chinese Medicine. Started Oct 2025; status: active, not recruiting.
02
Drugs
Guominkang
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT07907965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07907965.